Envestnet Asset Management Inc Verastem, Inc. Transaction History

Envestnet Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.92 - $11.16 $401 - $4,865	-436 Reduced 2.82%	15,010 $13,000
Q2 2022 Aug 03, 2022	BUY	$1.02 - $1.83 $1,104 - $1,981	1,083 Added 7.54%	15,446 $18,000
Q1 2022 May 04, 2022	BUY	$1.06 - $2.1 $588 - $1,165	555 Added 4.02%	14,363 $20,000
Q4 2021 Feb 04, 2022	BUY	$2.05 - $3.2 $28,306 - $44,185	13,808 New	13,808 $28,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.